ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2136

Does Functional Gain and Pain Relief After TKR and THR Differ By Patient Obese Status?

Wenjun Li1, Leslie R. Harrold2, Jeroan Allison3, Courtland Lewis4, Thomas Bowen5, Patricia D. Franklin1 and David Ayers1, 1Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 2University of Massachusetts Medical School, Worcester, MA, 3Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, 4Hartford Hospital, Hartford, CT, 5Geisinger, Danville, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: obesity, Osteoarthritis, Outcome measures, patient-reported outcome measures and total joint replacement

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis - Clinical Aspects II: Symptoms and Therapeutics in Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose: Obesity is an important predictor of functional status and pain after total knee (TKR) and total hip (THR) replacement. However, variations in pre-post TKR and THR changes in function and pain by obesity status remain to be examined. 

Methods: Pre- and 6 month post TKR data on physical function and pain were collected on 1,533 primary TKR and 1,118 primary THR patients between 5/2011 and 10/2012. Data included demographics, comorbidities, operative joint pain severity based on the Knee Injury/Hip Disability and Osteoarthritis Outcome Score (KOOS/HOOS), physical function (SF-36 PCS), mental health (SF-36 MCS), and musculoskeletal burden of illness.  Pre-post changes in PCS and pain were analyzed using descriptive statistics and linear mixed models that accounted for the clustering of patients within clinic. 

Results: Approximately 14% of TKR patients were under or normal weight (BMI<25), 33% overweight (BMI: 25.1-30), 29% obese (BMI: 30.1-35), 15% severely obese (BMI: 35.1-40) and 9% morbidly obese (BMI>40). Patients had average age of 67 years, included 61% women and 93% whites. Patients with greater level of obesity had lower PCS at baseline (p<0.001) and 6 month (p<0.001). However, pre-TKR to 6 month post-TKR change in  PCS  did not differ by level of obesity (p=0.554), and had an overall mean (SE) of 9.7 (0.23). Patients with greater levels of obesity had worse pain scores at baseline (p<0.001) but greater change in pain between pre-TKR and  6 months post-TKR (p=0.001). As a result, average pain scores at 6 months were similar across  levels of obesity (p=0.150), and had an overall mean (SE) of 84.9 (0.40).

Approximately 27% THR patients were under/normal weight (BMI<25), 38% overweight (BMI: 25.1-30), 23% obese (BMI: 30.1-35), 9% severely obese (BMI: 35.1-40) and 4% morbidly obese (BMI>40). Patients had average age of 66 years, included 62% women and 95% whites. Greater level of obesity was associated with lower PCS at baseline (p<0.001) and 6 month (p<0.001). Mean change in pre-to-six month PCS was greater in patients with BMI <35 when compared to BMI>35 ( 14 vs. 11.5)   Greater level of obesity was associated with a poorer baseline pain score (p<0.001) but larger change in post-op pain at (p=0.001). At 6 months, pain scores did not differ by level of obesity (p=0.068) with a mean score greater than 90.

Conclusion: At 6 months after TKR, severely obese patients (BMI>35) reported improvements in pain and function equal to or greater than patients with BMI<35.  At 6 months after THR, all patients reported significant functional gains although patients with BMI>35 had lower mean functional gain than those with BMI<35. All patients reported excellent pain relief.


Disclosure:

W. Li,

AHRQ,

2;

L. R. Harrold,

CORRONA, Inc.,

5;

J. Allison,

AHRQ,

2;

C. Lewis,
None;

T. Bowen,
None;

P. D. Franklin,

NIAMS-NIH, NLM-NIH, AHRQ, Zimmer, ,

2;

D. Ayers,

AHRQ, Zimmer,

2.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-functional-gain-and-pain-relief-after-tkr-and-thr-differ-by-patient-obese-status/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology